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Abstract  
 
The anti-viral T cell response is drawn from the naïve T cell repertoire. During influenza 
infection, the CD8
+
 T cell response to an H-2D
b
-restricted nucleoprotein epitope (NP366) is 
characterized by preferential expansion of TRBV13-1
+
 T cells and avoidance of TRBV17
+
 T cells, 
despite the latter dominating the naïve precursor repertoire. Two TRBV17
+
 TCRs bound H-2D
b
-
NP366 with a 180° reversed polarity compared to the canonical TCR-pMHC-I docking. The 
TRBV17 β-chain dominated the interaction and, while the CDR3 loops exclusively mediated 
contacts with the MHC-I, peptide specificity was attributable to germline-encoded recognition. 
Nevertheless, the TRBV17
+ 
TCR
 
exhibited moderate affinity towards H-2D
b
-NP366 and signaled 
effectively. Thus, the naïve CD8
+
 T cell pool can comprise TCRs adopting reversed pMHC-I 
docking modes that limit their involvement in the immune response. 
 
 
  
 3 
 
Introduction 
The immune system can theoretically produce 1015-1020 different αβT cell receptors (TCRs) (Davis and 
Bjorkman, 1988). Limitations imposed by thymic selection events causes the number of T cells in the 
naïve TCR repertoire to be reduced to ~2 x 106 in mice and around 2.5 x 107 in humans. Although 
substantial diversity remains in the naïve T cell repertoire, antigen-driven immune responses tend to 
exhibit highly reproducible TCR characteristics, or TCR bias, the extent of which can vary (Turner et 
al., 2006). In many cases, such antigen-driven biases are observed across multiple individuals 
suggesting reproducible selection of those characteristics. 
 
While some TCR bias may be ‘encoded’ in the naïve epitope-specific T cell repertoire, studies in TCR 
transgenic systems (Malherbe et al., 2004; Zehn et al., 2009) and endogenous polyclonal T cell 
populations (Busch and Pamer, 1999; Cukalac et al., 2015; La Gruta et al., 2010; Neller et al., 2015; 
Price et al., 2005) reveal that antigen-driven biases often arise during the immune response, as a 
consequence of selective recruitment and/or prolonged expansion of particular T cells. Indeed, the 
ability to directly compare endogenous, polyclonal epitope-specific CD8+ T cell repertoires before 
(Moon et al., 2007; Obar et al., 2008) and after antigen-driven expansion, has shown that archetypal 
TCR biases that define antigen-specific CD8+ T cell repertoires in humans and mice are not necessarily 
reflected in the naïve T cell pool (Cukalac et al., 2015; La Gruta et al., 2010; Neller et al., 2015). 
 
Although it is generally accepted that recruitment from the available epitope-specific T cell pool is 
comprehensive (van Heijst et al., 2009; Zehn et al., 2009), several studies have shown incomplete 
recruitment of T cell precursors. For example, analysis of epitope-specific TCRβ transgenic CD4+ and 
CD8+ T cells identified clones in the naïve repertoires that were not utilized in the immune response 
(Coles et al., 2003; Malherbe et al., 2004). Incomplete CTL precursor recruitment was also observed 
for endogenous CD8+ T cell populations following either vesicular stomatitis virus (VSV) or influenza 
A virus (IAV) infection of mice (La Gruta et al., 2010; Obar et al., 2008), and depletion of Treg cells 
prior to infection with Listeria monocytogenes resulted in the elicitation of a novel CD8+ T cell 
population (Pace et al., 2012).  
 
In addition to selection occurring at the level of T cell recruitment, once recruited, T cell clones show 
differing profiles of expansion. For example, while a broad range of precursors may undergo initial 
rounds of division, prolonged expansion is observed for those clones that recognize cognate pMHC 
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with relatively high affinity (Busch and Pamer, 1999; Malherbe et al., 2004; Price et al., 2005; Zehn et 
al., 2009). Consequently, the immune population becomes dominated by clones expressing optimal 
TCR characteristics (Miles et al., 2011; Turner et al., 2006). This is observed following HIV infection, 
where particular TCRs selected after natural infection have been associated with superior virus control 
(Chen et al., 2012; Dong et al., 2004), and in the HLA-A2-restricted CTL response to the IAV matrix-
derived peptide M158-66, where the response is comprised almost exclusively of TRBV19
+ T cells, 
despite diverse TRBV usage in the naïve repertoire (Neller et al., 2015). Collectively, these data reflect 
varying profiles of recruitment and expansion from the naïve T cell population that can significantly 
alter the profile of TCR usage in the immune response. 
 
During primary IAV infection of B6 mice, the immunodominant CD8+ T cell response is directed to an 
H-2Db-restricted nucleoprotein epitope (NP366) (Townsend et al., 1986), and is characterized by the 
preferential expansion of TRBV13-1+ T cells from the naïve repertoire (Deckhut et al., 1993; La Gruta 
et al., 2010). In contrast, the TRBV17+ T cell population, despite comprising around 25% of all naïve 
H-2Db-NP366-specific cells, contributes minimally to the immune response following viral infection 
(Cukalac et al., 2015). The TRBV17+ H-2Db-NP366-specific T cells thus provide a unique opportunity 
to interrogate the characteristics of a TCR-pMHC-I interaction that lacks the capacity for efficient 
immune selection. To date, our structural understanding of TCR recognition of pMHC-I is based 
largely on TCRs identified from immune repertoires (Rossjohn et al., 2015).  
 
We determined the structure of two TRBV17+ TCRs from the naïve CD8+ T cell repertoire in complex 
with H-2Db-NP366, and revealed a reversed docking topology relative to the established TCR-pMHC-I 
docking paradigm (Rossjohn et al., 2015), yet analogous to the reversed docking recently seen in the 
MHC-II system from a TCR isolated from an induced Treg cell (Beringer et al., 2015). Thus, naturally 
occurring T cells in the naïve pool express TCRs with reversed polarity pMHC-I docking modes that 
confer antigen specificity and functionality, but limit their ability to contribute to the immune response. 
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Results 
Poor expansion of TRBV17
+
 H-2D
b
-NP366-specific CD8
+
 T cells  
Comparison of TCR usage in CD8+ T cell populations specific for the IAV-derived NP366 epitope 
presented by H-2Db, before and after infection, revealed a dominance (~25%) of TRBV17 usage in the 
naïve repertoire, that falls to below 1% (1/149 sequences) following IAV infection (Cukalac et al., 
2015). The loss of TRBV17 representation is partly compensated by increased TRBV13-1 TCR usage 
from naïve (18%) to immune (~30-60%) T cell repertoires. To confirm the relative prevalence of 
TRBV17 and TRBV13-1 usage in immune H-2Db-NP366-specific populations, H-2D
b-NP366 tetramer
+ 
CD8+ populations, isolated from lung draining lymph node (mediastinal lymph node; mLN), spleen, 
and bronchoalveolar lavage (BAL) isolated at the peak of the CD8+ T cell response (d10 after 
infection), were stained with antibodies specific for TRBV17 (anti-Vβ9) and TRBV13-1 (anti-Vβ8.3). 
Confirming our earlier results derived from TCR sequence analysis (Cukalac et al., 2015), TRBV13-1+ 
T cells comprised around 50% of H-2Db-NP366-specific cells across all tissues, while <1% of T cells 
were TRBV17+ (Fig. 1a,b). Similar results obtained at d7 after IAV infection demonstrated that, 
despite their prevalence in the naïve T cell repertoire, TRBV17+ T cells contributed minimally over the 
course of the antiviral CTL response (Fig. 1b). Importantly, like TRBV13-1+ H-2Db-NP366-specific T 
cells, the TRBV17+ subset showed upregulated CD44 expression after infection, indicative of 
activation and recruitment into the response (Fig. 1a). Combined with our previous observation that the 
naïve H-2Db-NP366-specific CTL precursor pool is comprehensively recruited into the response (La 
Gruta et al., 2010), these data suggest that the paucity of TRBV17+ H-2Db-NP366-specific T cells in the 
immune response is due to a failure to undergo extensive proliferation once recruited. Accordingly, 
TRBV17+ H-2Db-NP366-specific T cells, whilst highly abundant in the naïve CD8
+ T cell repertoire, are 
very rare in the immune repertoire.  
 
TRBV17
+
 H-2D
b
-NP366-specific T cells show moderate affinity for pMHC-I 
Following antigen encounter, comprehensive CD8+ T cell recruitment, but truncated expansion, is a 
characteristic of CD8+ T cells with relatively low pMHC-I affinity (Zehn et al., 2009). To determine 
the relative TCR avidity of TRBV17+ and TRBV13-1+ cells, the MFI of H-2Db-NP366 tetramer staining 
on d10 immune populations was determined. Tetramer MFI was significantly lower on polyclonal 
TRBV17+ T cells compared to TRBV13-1+ T cells at d10 post-infection (Fig. 1c), despite an overall 
similar level of TCR expression (Supplemental Fig. 1a), indicative of a lower avidity of TRBV17+ 
TCRs for H-2Db-NP366, relative to the TRBV13-1
+ T cell subset. 
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We next transfected 293T cells with five TRBV13-1+ TCRs and two TRBV17+ TCRs (NP1-B17 and 
NP3-B17), (Supplemental Table 1) identified from the H-2Db-NP366-specific repertoire (Cukalac et 
al., 2014; Cukalac et al., 2015). For a given amount of surface TCR expression (Fig. 1d and data not 
shown), all five TRBV13-1+ TCRs bound significantly more tetramer than the TRBV17+ TCRs, which 
could only detectably bind tetramer at high TCR levels (Fig. 1d,e), again indicating a reduced 
TRBV17+ TCR affinity for H-2Db-NP366 compared to TRBV13-1
+ TCRs. Next, to determine the 
affinity of the TRBV17+ TCR for H-2Db-NP366, we expressed two soluble TRBV17
+ TCRs (NP1-B17 
and NP2-B17) (Supplemental Table 1) (Cukalac et al., 2015) and performed surface plasmon 
resonance (SPR) analysis (Table 1 and Fig. 1f). The TRBV17+ TCRs bound H-2Db-NP366 with a 
dissociation constant (Kd) of ~40 and 30 µM, for NP1-B17 and NP2-B17, respectively, which is well 
within the established range of TCR-pMHC-I binding affinities (Kd = ~1-100 µM), but at the lower end 
of the spectrum for viral epitope recognition (typically 1-10 µM) (Rossjohn et al., 2015). Accordingly, 
the TRBV17+ TCRs have a lower avidity than TRBV13-1+ TCRs. 
 
Inefficient H-2D
b
-NP366-specific TRBV17
+
 T cell expansion is intrinsic  
To further assess the relative potential of TRBV17+ and TRBV13-1+ H-2Db-NP366-specific T cells after 
antigen encounter, TCR retrogenic (Rg) mice were generated (Holst et al., 2006), expressing either a 
TRBV17+ (NP1-B17) TCR or a TRBV13-1+ TCR (NP1-B13) (Supplemental Table 1). Post-
reconstitution, both TRBV17+ and TRBV13-1+ naïve Rg CD8+ T cells bound H-2Db-NP366 tetramer 
(Fig. 1g), although, notably, the TRBV17+ T cells bound tetramer more poorly than the TRBV13+ T 
cells. Adoptive transfer to recipient wildtype (WT) mice of equivalent numbers of TRBV17+ and 
TRBV13-1+ Rg CD8+ T cells either in combination or alone, followed by IAV infection (Fig. 2a), 
resulted in a notably larger number of TRBV13-1+ (compared to TRBV17+) cells by d10 (Fig. 2b). 
This was observed across multiple tissues, and represented an average expansion of 1400-fold for 
TRBV13-1+ T cells and 150-fold for TRBV17+ T cells (Fig. 2b).  
 
Polyfunctionality in T cells has been correlated with improved disease outcomes (Seder et al., 2008). 
Functional analysis of the TRBV17+ and TRBV13-1+ Rg CD8+ T cells after IAV infection revealed 
distinct cytokine profiles associated with the extent of division. Namely, a significantly larger 
percentage of TRBV13-1+, compared to TRBV17+, Rg cells from both lung and spleen produced IFNγ 
after short term in vitro peptide-specific restimulation, irrespective of whether the Rg cells were 
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transferred independently or together (Fig. 2c and Supplemental Fig. 1b). Of those IFNγ+ cells, a 
significantly larger proportion of the TRBV13-1+ T cells, compared to TRBV17+ T cells, also produced 
TNF, although no difference was observed in the percentage of IFNγ+ cells producing IL-2 (Fig. 2c), 
nor in the percentage or MFI of granzyme B producing cells (Supplemental Fig. 1c,d).  
 
Given these observations, we assessed the relative abilities of the TRBV17+ and TRBV13-1+ T cells to 
transduce a signal upon TCR ligation. Here, ERK1/2 T202/Y204 phosphorylation was detected in Rg T 
cells. In the absence of peptide, no signal was detected from either the TRBV13-1+ or the TRBV17+ Rg 
cells, showing that recognition of pMHC-I was epitope-specific, whereas robust ERK1/2 T202/Y204 
phosphorylation was evident after crosslinking either TCR with anti-CD3ε Ab (Fig. 2d). In the 
presence of the NP366 peptide, phosphorylated ERK1/2 could be detected in both TRBV13-1
+ and 
TRBV17+ Rg cells at 10 minutes post-activation, but at 45 min only the TRBV13-1+ cells were able to 
maintain detectable levels of phosphorylated ERK1/2 (Fig. 2d).  
 
Collectively, while TRBV17+ T cells are recruited into the H-2Db-NP366-specific response, they are 
intrinsically inferior to the TRBV13-1+ subset with respect to both proliferative capacity and 
functionality, which is associated with a reduced signaling capacity and moderate affinity for pMHC-I. 
 
Reversed polarity of TRBV17
+
 TCR recognition of H-2D
b
-NP366 
To investigate the structural basis for the poor TRBV17+ T cell recruitment, we refolded two 
TRBV17+ TCRs (NP1-B17 and NP2-B17, Supplemental Table 1), and determined the structure of the 
ternary complexes (Fig 3, Supplemental Table 2). These two TCRs differ in their CDR3α and CDR3β 
sequences (Supplemental Table 1), thereby also providing insight into how this variability impacted 
on H-2Db-NP366 recognition. The two TRBV17
+ TCRs docked onto the H-2Db-NP366 complex in a very 
similar fashion (Fig. 3a,b) but, strikingly, with a reversed topology compared to all other TCR-pMHC-
I structures solved to date (Fig. 3c) (Rossjohn et al., 2015). Namely, whilst the α- chain and β-chain of 
previously published TCRs were universally observed to dock over the α2- and α1-helix of MHC-I, 
respectively (Fig. 3c), the α- and β-chains of the TRBV17+ TCRs sat over the α1- and α2-helices, 
respectively (Fig. 3a,b). Here, the TRBV17+ TCRs were located at the carboxy-terminal end of the H-
2Db antigen-binding cleft, forming a docking angle of 237° (Fig. 3a,b), which is approximately 180° 
from the mean docking angle (~63°) typically observed for TCR-pMHC-I interactions (Fig. 3c) 
(Rossjohn et al., 2015). The reversed docking observed for the TRBV17+ TCRs were distinct from that 
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of the iTreg TCR-pHLA-DR4 complexes recently described (Beringer et al., 2015) (Fig. 3d and 
Supplemental Fig. 2a). Indeed, the TRBV17+ TCRs-H-2Db-NP366 docking footprints were more 
reminiscent of the KIR3DL1-pHLA-I interaction (Vivian et al., 2011) (Supplemental Fig. 2b). 
 
As the NP1-B17 and NP2-B17 TCRs docked similarly onto the H-2Db-NP366 complex (Fig. 3a,b) (root 
mean square deviation of 0.81 Å on the overall complex), we describe below the molecular basis of the 
higher resolution complex, namely the NP1-B17 TCR. Despite the reversed polarity of TCR docking, 
the NP1-B17 TCR-H-2Db-NP366 binding was typical with respect to both buried surface area (BSA) at 
the TCR-pMHC-I interface (~1,870 Å2 compared to an average of ~1,900 Å2) (Rossjohn et al., 2015) 
and the extent of interactions with the MHC-I molecule (Table 2). Here, the TCR α-chain played a 
limited role (30% BSA) in interacting with H-2Db-NP366. Specifically, only the CDR3α loop contacted 
H-2Db-NP366, while the germline-encoded regions of the TCR α-chain were too remote from the 
interface to contribute to binding (Fig. 3a). In contrast, the TCR β-chain contributed 70% of the BSA, 
underscoring the TRBV17 bias towards H-2Db-NP366 (see below). Here, the CDR2β loop (26% BSA) 
and the framework region of the β chain (FWβ) region (37% BSA) contributed substantially to the 
interaction with the H-2Db-NP366 (Fig. 3a). Accordingly, MHC-I restricted TCRs, isolated from the 
naïve T cell repertoire, can adopt a reversed TCR-pMHC-I docking topology. 
 
Atypical contacts underpin the TRVB17
+
 TCR-H-2D
b
 interaction 
The NP1-B17 and NP2-B17 TCRs bound two regions of MHC-I that have not been previously 
observed to mediate TCR binding (Table 2, Fig. 3ab and Fig. 4a). Namely, the CDR3α loop bound 
two H-2Db loops (residues 14-21 and 85-92) that are situated outside of the antigen-binding cleft, being 
located after the first β-strand and at the end of the α1-helix, respectively (Fig. 4a). Here, the CDR3α 
loop acts as a peg that fills the notch between these two H-2Db loops (Fig. 4a), where large charged 
side chains from H-2Db stabilized the CDR3α loop via a network of polar and non-polar interactions. 
Namely, Trp113α wedged between the Arg75 and Arg79, Glu108α, salt-bridged to Arg79, while 
Ser112α hydrogen bonded to Glu18 and the Arg75 (Fig. 4a). These CDR3α loop mediated contacts 
were conserved between the NP1-B17 and NP2-B17 TCRs. While the CDR3α loop made substantial 
contact with the MHC-I molecule, it did not engage the peptide (Table 2 and Fig. 3a,b). Conversely, 
the CDR3β loops of the NP1-B17 and NP2-B17 TCRs engaged the MHC-I via one (Leu110β) or two 
residues (Leu110β and Asp111β), respectively, and made no contacts with the peptide (Fig. 4b and 
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Table 2). Thus, the extent of involvement and role of the CDR3 loops in these TRBV17+ TCR-H-2Db-
NP366 complexes is in stark contrast to all the TCR-pMHC-I complexes observed to date (Rossjohn et 
al., 2015). 
 
The CDR2β loop and the framework segment of the β-chain (FWβ) made the majority of the contacts 
with the MHC-I (Fig. 4c,d). Here, the CDR2β loop sat over the H-2Db α1-helix, where Tyr57β and 
Ile64β interacted with Gln72 and Gly69 & Trp73, respectively (Fig. 4c). A large stretch of 11 residues 
(66 to 77) from the FWβ region contacted both the α1- and α2-helices of the H-2Db molecule (Fig. 4d 
and Table 2). Here, the side chain of the Asn66β formed a hydrogen bond with Asn80, and van der 
Waals interaction with Val76 from the α1-helix (Fig. 4c), while the FWβ region interacted with a 
focused region (142-150) of the α2-helix (Fig. 4d). Prominently, Arg67β lay flat in a head-to-tail 
orientation on the top of Lys146 (Fig. 4d), with the positively charged head groups forming a hydrogen 
bond with their respective main chains. Collectively, the extent of interactions with the TCR β-chain 
provided insight into the TRBV17 bias, and very unusual interactions underpinned this reversed TCR-
pMHC-I docking mode. 
 
Germline-encoded recognition of the NP366 peptide 
In all of the TCR-pMHC-I structures solved to date, at least one of the non-germline encoded CDR3 
loops is involved in contacting the peptide (Rossjohn et al., 2015). However, neither of the TRBV17+ 
TCR CDR3 loops contacted the NP366 peptide. Instead, peptide contacts were mediated solely by the 
TCR β-chain germline-encoded residues (Fig. 3a,b and Table 2). Specifically, the CDR2β and FWβ 
region formed a “lid-like” structure with the C-terminal end of the peptide (Asn5-Thr8) (Fig. 4e). Here, 
Asn5 and Met6 formed main chain interactions with Ile64β from the CDR2β loop, while the aliphatic 
moiety of Glu7 packed against Leu65β from the CDR2β loop, and its carboxyl group salt-bridged to 
Arg67β from the FWβ region (Fig. 4e). Thr8 formed van der Waals interactions with Ile64β and 
Leu65β of the CDR2β loop, as well as hydrogen bonding to the main chain of the Leu65β and the side 
chain of the FWβ-Asn66. In addition, the small size of Thr8 permitted an intricate network of 
interactions between the TCR and the MHC (not shown). In summary, the TRBV17+ TCR engaged the 
peptide in an unprecedented manner, whereby the germline-encoded regions of the TRBV17 chain 
solely dictated peptide specificity. 
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TRBV17
+
 TCR displays a large energetic footprint on H-2D
b
  
We next established the energetic basis underpinning the NP1-B17 TCR interaction by a large alanine-
scanning mutagenesis study. Based on the crystal structure, 22 mutant pMHC-I complexes were 
generated (15 H-2Db and 7 NP366 mutants) (Table 1) (Burrows et al., 2010). We first checked the 
thermal stability of the 23 pMHC-I complexes generated (Supplemental Table 3). The H-2Db-NP366 
complex showed a thermal melting point (Tm) of ~50°C and all but two of the mutants (H-2D
b-K146A 
(~41°C) and NP366 mutant A1N (~43°C)), were as stable as the H-2D
b-NP366, allowing us to assess the 
importance of each mutated position in mediating NP1-B17 TCR recognition. 
The affinity of the NP1-B17 TCR, as measured by SPR, for each H-2Db or peptide mutant was 
compared to the H-2Db-NP366 WT, with the effect classified as negligible if the affinity was decreased 
by less than three-fold, moderate if the affinity decreased by three to five-fold, and critical (“hot spots”) 
if the affinity changed by more than five-fold. As expected, the control triple mutation of MHC 
residues (positions 65, 69 and 155) (Burrows et al., 2010; Tynan et al., 2005) had no impact on NP1-
B17 TCR recognition (Fig. 5a and Table 1). Of the other 14 H-2Db single site mutants tested, seven 
did not impact the NP1-B17 TCR affinity, three had a moderate impact and five were critical for the 
NP1-B17 TCR recognition (Fig. 5a, Table 1 and Supplemental Fig. 3).  
 
The hot spots were clustered at the C-terminal region of the antigen-binding cleft (Arg75, Val76, 
Arg79, Asn80 and Lys146), surrounded by the three moderately important amino acids (Glu18, Ala89, 
Gln149) (Fig. 5a and Table 1). Two of the moderate mutations (Glu18 and the Ala89) were located in 
the loops (14-21 and 85-92) (Rossjohn et al., 2015), thereby underpinning the importance of this 
atypical region in mediating NP1-B17 TCR contacts. Notably, Arg75 and Arg79 formed interactions 
with the CDR3α and CDR3β loops, while the FWβ region mediated 3 critical contacts with the H-2Db 
molecule; Asn80, Val76, and Lys146, (Table 1 and Fig. 5a). Accordingly, the energetic footprint 
highlighted the critical contribution of the CDR3 loops in mediating interaction with the MHC 
molecule. 
 
Peptide specificity of the reversed docking CD8
+
 TCR 
Next we determined the extent to which the TCR was dependent on the NP366 peptide for recognition 
of the H-2Db-NP366 complex. Here, SPR analysis was performed using H-2D
b loaded with unrelated 
peptide (namely PA224-233, derived from the acid polymerase protein of IAV, or GAP50, derived from 
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the malaria PbA glideosome-associated protein 50 (Gordon et al., 2015)), or with NP366 peptide 
mutants. Neither the PA224-233 nor the GAP50 peptide bound to H-2D
b showed any interaction with the 
NP1-B17 TCR, indicating that this interaction is peptide dependent. The Ala1 did not contact the NP1-
B17 TCR, but had a moderate impact on TCR affinity (Table 1), which is likely an indirect 
consequence of decreased stability of the H-2Db-NP366-A1N (Supplemental Table 3). The mutation of 
the NP366 epitope at positions 3, 4 and 6 had no impact on NP1-B17 TCR affinity, despite being critical 
for recognition by polyclonal immune H-2Db-NP366-specific CD8
+ T cells (Turner et al., 2005). 
However, both Glu7Ala and Thr8Ala mutations dramatically decreased, by more than five-fold, the 
NP1-B17 TCR affinity (Table 1).  
 
The Glu7 and the Thr8 residues of the NP366 epitope contacted the CDR2β and the FWβ regions of the  
NP1-B17 TCR (Table 2). The NP366 epitope hot spots were co-located with the H-2D
b hot spots, 
thereby indicating that the C-terminal end of the antigen-binding cleft represented the focal point of the 
TCR interaction (Fig. 5a). Thus, despite the reversed docking mode adopted by the NP1-B17 
TRBV17+ TCR, and the lack of CDR3 loops interaction with peptide, it mediated a peptide-specific 
interaction. 
 
TRBV17
+
 TCR signaling corresponds to the affinity of the TCR-pMHC-I interaction 
To support the contention that the reverse docking topology is responsible for the poor involvement of 
TRBV17+ T cells in the IAV-specific immune response, we introduced 16 single alanine mutations in 
the NP1-B17 TCR (15 residues that contact the pMHC-I, and 1 control residue (Val59α) that does not 
contact the pMHC-I) (Fig. 5b,c). Upon transducing these 16 mutant TCRs into a Jurkat T cell line, we 
assessed the ability of the mutant TCRs to transduce a signal (via pERK1/2 staining) following specific 
recognition of H-2Db-NP366. The impact of mutation was classified as negligible if pERK1/2 staining 
was >60% of that observed with the WT NP1-B17 TCR staining; moderate if it fell between 10-60%; 
and critical if there was <10%. The control (Val59α) mutation had no effect on signaling (Fig. 5b,c). 
Three other TCR mutants, all belonging to the CDR3α loop (Glu108α, Gly111α and Gln114α), also 
had no impact on signaling. Five residues showed a moderate impact on T cell signaling, namely three 
from the CDR3α  loop (Thr109α, Ser110α and Ser112α) and two from the FWβ region (Phe72β and 
Glu74β) (Fig. 5b,c). Notably, seven residues were critical for T cell signaling, as their alanine 
substitution abrogated the pERK1/2 response. The critical residues were Trp113α and Leu110β from 
the CDR3α and CDR3β loops respectively; Tyr57β, Ile64β and Leu65β from CDR2β; and the FWβ 
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residues Asn66β and Arg67β. All the critical TCR residues mediated interactions with the MHC and/or 
peptide, and there was a very close correlation between key peptide and MHC residues impacting on 
affinity of the interaction and the corresponding TCR residues impacting on T cell signaling.  
Moreover, all the TCR residues, namely Ile64β, Leu65β, Asn66β and Arg67β contacting the peptide 
were critical for T cell signaling (Fig. 5b, c). Collectively these data demonstrate that impacting the 
affinity of the TCR-pMHC-I interaction has a direct and corresponding impact on T cell signaling. 
 
TRBV17
+
 T cells and MHC-restriction 
Given the reversed polarity docking topology and the moderate affinity of the selected H-2Db-NP366 
reactive TRBV17+ T cells, we investigated the possibility that these T cells depended on H-2Kb for 
positive selection in the thymus, and cross-reacted with H-2Db-NP366 in the periphery. Because ~25% 
of the H-2Db-NP366-specific repertoire is comprised of TRBV17
+ T cells (Cukalac et al., 2015), the 
absence of H-2Kb would, in that case, result in a substantial reduction in both the number and TRBV17 
usage of naïve H-2Db-NP366-specific cells. The H-2K
b-/- mice had a substantially larger proportion of 
CD8+ T cells compared to mice lacking both H-2Kb and H-2Db, indicating that the vast majority of T 
cells present in H-2Kb-/- mice are selected on H-2Db (Fig. 5d) (Perarnau et al., 1999). Both H-2Kb-/- 
and WT mice were equally capable of generating naïve H-2Db-NP366-specific CD8
+ T cells (Fig. 5e), 
with similar TRBV17 usage by such cells in both strains (Fig. 5f). Thus, the H-2Db-NP366-specific 
TRBV17+ population is not dependent on H-2Kb for thymic development, and is most likely selected 
on H-2Db. 
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Discussion 
The factors that contribute to the recruitment and expansion of T cells from the naïve repertoire into the 
immune repertoire are complex and unclear. In some cases, even following infection, a subset of the 
epitope-specific naïve pool remains unrecruited (Coles et al., 2003; La Gruta et al., 2010; Malherbe et 
al., 2004; Obar et al., 2008). Moreover, direct comparison of TCR usage in naïve and immune epitope-
specific T cell repertoires revealed that some T cells, whilst abundant in the naïve repertoire, are 
nevertheless greatly and reproducibly diminished in the immune repertoire upon viral challenge 
(Cukalac et al., 2015; Neller et al., 2015). These findings demonstrate that the extent of involvement of 
particular T cell clones in the immune response is selective. Here we provide mechanistic insight into 
this observation, revealing that a minimal contribution to the immune repertoire can correlate with a 
reversed TCR-pMHC-I docking topology. 
 
The diminished prevalence of TRBV17+ T cells in the IAV-specific immune repertoire was not 
attributable to the TRBV17+ T cells being redistributed to a distinct tissue/organ or being selected on 
another restriction element. Moreover, the observation that the fold expansion of each Rg T cell 
population (TRBV13-1+ or TRBV17+) was reproducible, irrespective of whether they were transferred 
separately or together, or in the presence or absence of an endogenous IAV-specific CD8+ T cell 
response, indicates that the poor responsiveness of the TRBV17+ T cell population is intrinsic and 
unrelated to competition with other responding T cell populations. The reduced capacity of the 
TRBV17+ TCRs to contribute to the IAV-specific immune response is possibly due to the relative low 
avidity of the TRBV17+ T cells towards H-2Db-NP366 compared to that of the TRBV13-1
+ T cell 
population (Busch and Pamer, 1999; Cukalac et al., 2014; McHeyzer-Williams et al., 1999; Price et al., 
2005). Mutational analyses demonstrated that the relative impact of disrupting TCR-pMHC-I affinity, 
correlated with the extent of impact on T cell signaling. Thus, the nature of the reversed TCR-pMHC-I 
interaction drives, in part, the efficiency (or lack thereof) of signaling and therefore activation. 
 
Another aspect by which a reversed TCR-pMHC-I docking topology may result in poor activation of T 
cells centers on our understanding of the structural organization of the TCR/pMHC/co-receptor 
complex (Yin et al., 2012) and the CD3 docking site on TCRβ (Birnbaum et al., 2014; He et al., 2015). 
Here, the CD3 complex is located within an arch-like structure on the T cell surface and is thus co-
localized with both TCRαβ and co-receptor-associated Lck, facilitating the phosphorylation of CD3 
ITAMs (He et al., 2015; Rangarajan and Mariuzza, 2014; Yin et al., 2012). Accordingly, a reversed 
TCR docking polarity would place the CD3 complex outside of the arch, thereby reducing its proximity 
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to Lck and consequently the efficiency of ITAM phosphorylation (Rangarajan and Mariuzza, 2014; Yin 
et al., 2012). While the quaternary TCR/pMHC-I/CD8 complex structure has not been solved, a similar 
structural organization likely applies for CD8+ T cells (Yin et al., 2012). In this way the reverse 
docking topology may negatively impact the efficiency of signaling independently of TCR-pMHC-I 
affinity. In summary, the associated functionality of the TRBV17+ T cells were inferior to that of the 
TRBV13-1+ T cells, implying that this is related to the way in which TRBV17+ TCRs engaged the 
pMHC-I. 
 
In MHC-restricted immunity, the TCR has universally (with one prominent exception (Beringer et al., 
2015)) adopted a consensus polarity above the MHC. This consistent polarity of the TCR-pMHC 
docking mode has been the key argument pertaining to TCRs being hard-wired to interact with the 
MHC (the germline-encoded model) (Garcia et al., 2009). An extension to this TCR hard-wiring 
concept is the “interaction codon hypothesis” pertaining to TCR-pMHC interactions, which posits that 
conserved pairwise interaction motifs between the germline-encoded regions of the TCR and the MHC 
underpin this TCR-MHC co-evolution (Adams et al., 2016). In contrast to the germline model, the 
selection model argues that MHC restriction is not an intrinsic feature of TCRs but is conferred by 
selection events in the thymus (Holland et al., 2012; Van Laethem et al., 2013). Here we show that the 
two TRBV17+ TCRs, which are found within the naïve T cell repertoire in wild type mice, adopt a 
reversed TCR-pMHC-I docking topology. Moreover, within this reversed TCR-pMHC-I framework, 
the non-germline-encoded CDR3 loops exclusively contacted the MHC-I molecule. It is difficult to 
reconcile these structural features of a naturally selected TCR, as well as that recently observed in the 
TCR-pMHC-II setting (Beringer et al., 2015), within the framework of the germline-encoded model of 
TCR recognition.  
 
Alternatively, the fact that such variations on the consensus docking mode have not been seen in the 
TCR-pMHC-I structures solved to date, as well as our current demonstration of the relative inability of 
a variant docking mode to support efficient immune selection, may suggest that this non-canonical 
docking mode is the exception that proves the rule of germline selection. However, this is the first 
ternary complex structure of antigen-specific TCRs from the naïve repertoire and so the frequency of 
unconventionally docked TCRs in this pool is unknown. It is possible that thymic selection permits a 
much broader range of TCR-pMHC interactions – the signaling threshold for thymic selection is lower 
than that required for peripheral T cell activation (Davey et al., 1998; Hogquist et al., 1994) - and that 
the infrequency of unconventional TCR-pMHC recognition in immune repertoires reflects a further 
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‘selection’ event beyond thymic selection. Resolution of further naïve TCR-pMHC structures is 
therefore essential.  
 
Our observation clearly resonates with the recently described reversed polarity observed in a TCR-
pMHC-II setting (Beringer et al., 2015). While the MHC-II restricted TCR originated from the naïve T 
cell repertoire, it was nevertheless isolated from an induced Treg cell, and the reversed docking mode 
was suggested to be a mechanism related to Treg fate (Beringer et al., 2015). We now show that 
reversed TCR docking can also be a salient determinant of why certain T cells, whilst abundant in the 
naïve repertoire, are not selected into the immune repertoire. This would also explain why this docking 
mode has not been observed in previous structural analyses, which have focused on TCRs identified 
from immune populations. These findings demonstrate that the naïve CD4+ and CD8+ T cell repertoire 
expresses TCRs that can latch onto the MHC in reversed polarity docking modes. Together with the 
reports that TCRs can ligate non-MHC molecules in co-receptor deficient mice (Tikhonova et al., 2012; 
Van Laethem et al., 2007) or mice in which Lck is freed from the CD4 and CD8 co-receptors (Van 
Laethem et al., 2013), it suggests that TCRs can bind the MHC in a number of distinct modes that are 
neither limited to docking geometries or signaling constraints. However, here we demonstrate that the 
reversed TCR-pMHC-I docking is coincident with a diminished contribution to the immune repertoire. 
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Experimental Procedures 
Mice and virus infection 
Female C57BL/6J (H-2b) WT, H-2Kb-/-, H-2Kb/Db-/- (Perarnau et al., 1999), OTI TCR transgenic, 
RAG1-/-, and TCRα-/- mice were bred and housed in the animal facility of the Department of 
Microbiology and Immunology, University of Melbourne (Parkville, Australia). Naïve 6-10 week-old 
mice were infected i.n. with 1 x 104 PFU of HKx31 (H3N2) influenza A virus (La Gruta et al., 2004). 
All animal experimentation was reviewed and approved by the University of Melbourne Animal Ethics 
Committee. 
Tetramer and antibody staining 
Enriched single cell suspensions from mLN, spleen, and BAL from mice at d10 after primary IAV 
infection were stained with PE- or APC-conjugated tetrameric complexes of H-2Db MHC class I 
glycoprotein loaded with nucleoprotein-derived NP366–374 (ASNENMETM) (ImmunoID, University of 
Melbourne), along with fluorescently conjugated antibodies to CD8α, and either anti-Vβ9 (TRBV17) 
or anti-Vβ8.3 (TRBV13-1), as described (Cukalac et al., 2015). 
In vitro TCR expression 
293T cells were transfected with a bicistronic mouse stem cell virus (MSCV)-based retroviral vector 
containing αβTCR sequence with IRES-GFP (pMIGII) or IRES-mCherry (pMImC), as well as pMIGII 
encoding the CD3γδε and ζ subunits (Szymczak et al., 2004). Transfected 293T cells were labelled 
with H-2Db-NP366-APC tetramer 48 h later, followed by fluorescently conjugated anti-CD3ε and anti-
TCRβ Abs. Alternatively, Jurkat-76 (Jurkat) cells were stably transduced with pMIGII retrovirus 
(Szymczak et al., 2004) encoding one of 16 mutant NP1-B17 TCRs (Fig. 5 and Table 2). 
Generation of retrogenic mice and adoptive transfer 
Retrogenic mice expressing either the NP1-B17 or NP1-B13 TCRs were generated according to a 
published protocol (Holst et al., 2006), using bone marrow cells from RAG1-/- mice. Bone marrow 
reconstitution was verified by analysis of blood leucocytes ~6 weeks post-transplant. NP1-B17 or NP1-
B13 Rg T cells (2.5 x 103) from pooled spleen and lymph nodes (sorted on the basis of CD8, CD3, and 
either GFP or mCherry co-expression) were transferred either separately or together into recipient WT, 
RAG1-/- or OTI TCR transgenic mice, followed by i.n. infection with IAV.  
Magnetic enrichment of naïve epitope-specific CD8
+
 T cells 
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Tetramer-based magnetic enrichment was used for identification of naïve epitope-specific CTLps in 
WT B6 and H-2Kb-/- mice, as described in detail previously (La Gruta et al., 2010; Moon et al., 2007; 
Obar et al., 2008). Entire samples were acquired on a FACSAria III cell sorter with FACSDiva 
software (BD Immunocytometry Systems, San Jose, CA, USA). 
Intracellular cytokine staining 
Mice that had received Rg CD8+ T cells were administered i.n. with IAV the following day and then 
spleen and BAL were harvested at d10 post-infection. Enriched cell populations were then incubated 
with or without NP366 peptide (1µM) at 37°C, 5% CO2 for 5h, before surface staining with 
fluorescently labelled anti-CD8α followed by permeabilization, fixation and intracellular staining for 
IFN-γ, TNF, and IL-2 using BD Cytofix/Cytoperm kit (La Gruta et al., 2004). 
T cell signaling 
Peptide pulsed bone marrow derived dendritic cells (BMDCs) and DC2.4 cells (provided as a kind gift 
from Professor Kenneth Rock, University of Massachusetts Medical School) were incubated with 
GFP+ retrogenic NP1-B17 or NP1-B13 cells or Jurkat transductants expressing NP1-B17 wt or mutant 
TCRs, respectively. Cells were spun together to allow conjugation for the indicated timepoints, stained 
for pERK1/2 expression, and analyzed by flow cytometry. For more details see Supplemental 
Experimental Procedures. 
Protein expression, purification, crystallisation and structure determination 
The NP1-B17 and NP2-B17 TCRs as well as the wt and mutants pMHC complex were expressed, 
refolded and purified as previously described (Day et al., 2011). Further details are included in 
Supplemental Experimental Procedures.  
 
Thermal stability assay 
To assess the effect of each mutation on the pMHC complex stability, a thermal shift assay was 
performed using fluorescent dye Sypro orange to monitor the protein unfolding as previously described 
(Gras et al., 2012). Results are reported in Supplemental Table 3. 
 
Surface Plasmon Resonance Measurement and Analysis 
All surface plasmon resonance experiments were conducted at 25°C on the BIAcore 3000 instrument 
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with 10mM Tris-HCl, pH 8, 150mM NaCl, 0.005% surfactant P20 and 1% BSA buffer. The NP1-B17 
and NP2-B17 TCRs, as well as a negative control (LC13 (Gras et al., 2009)), bound to a CM5 sensor 
chip via amine coupling, and the pMHC was flown over the TCRs with a maximum concentration of 
0.78-200 µM. The experiment was conducted as previously described (Gras et al., 2009) in duplicate 
with n=2. BIAevaluation Version 3.1 was used for data analysis with the 1:1 Langmuir binding model, 
the results are summarized in Table 1. 
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Figure Legends 
Figure 1. TRBV17
+
 T cells contribute minimally to the H-2D
b
-NP366-specific anti-viral response 
and exhibit reduced affinity. (a) Flow cytometric dot plots showing the proportion of CD8+ T cells 
recovered from BAL at d10 after i.n. IAV infection that are tetramer+ (left) and the proportion of 
tetramer+ CD8+ T cells that are TRBV+ (right). (b) Percentage of the H-2Db-NP366-specific CTL 
response using TRBV17 or TRBV13-1 TCRs in the mLN, spleen and BAL at d7 or d10 after IAV 
infection. (c) Tetramer MFI on TRBV17+ or TRBV13-1+ H-2Db-NP366-specific CTLs at d10 after IAV 
infection. Shown are data points from 9 individual mice and the mean +/- standard deviation. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001 using Student’s paired t test for (b) and (c). (d) At 48h after 
transfection of 293T cells with vectors encoding the designated TCRαβ and CD3γδε and ζ, cells 
expressing no TCR (black), intermediate TCR (open grey) or high TCR (dashed, grey fill) levels were 
analyzed for levels of tetramer staining. (e) H-2Db-NP366 tetramer MFI was determined for five 
different TRBV13-1 TCRs and two TRBV17 TCRs at each of the stated levels of TCR. Data is 
representative of 2 independent experiments. (f) Binding response of NP1-B17 (LHS) and NP2-B17 
(RHS) TCRs against H-2Db-NP366 complex as analyte. The SPR sensograms represent the binding of a 
concentration range of H-2Db-NP366 (0.78-200 µM), from a single experiment, with the standard error 
of the mean represented (n=2). (g) CD8+ T cells from blood of naïve NP1-B17 or NP1-B13 Rg mice 
were stained with H-2Db-NP366 tetramer and the levels of tetramer staining on GFP
+ cells (expressing 
equivalent TCR) from 8 individual Rg mice are shown. 
Figure 2. Diminished expansion and function of adoptively transferred TRBV17
+
 Rg cells after 
IAV infection. (a) NP1-B17 and NP1-B13 CD8+ Rg cells (2,500 cells), identified by GFP or mCherry 
expression in 8-12 week old Rg mice, were adoptively transferred either separately or in combination 
into recipient WT B6 mice and mice were infected i.n. with IAV the following day. (b) Rg cells shown 
as a proportion of the total CD8 population in mLN, spleen and BAL at d10 after IAV infection, and 
fold expansion in the spleen relative to input number. (c) Cells recovered from spleen and BAL at d10 
following IAV infection were stimulated in vitro for 5h with NP366 peptide and IFN-γ, TNF, and IL-2 
production determined by ICS. Shown are results from mice receiving either NP1-B17 or NP1-B13 
cells. 3 mice/group for (b), 5 mice/group for (c) (d) NP1-B17 or NP1-B13 CD8+ Rg cells were 
incubated with BMDCs pulsed with or without NP366 peptide, or were incubated with anti-CD3ε Ab. 
Cells were removed after stimulation for either 10 or 45 min and phosphorylated ERK1/2 was stained 
with a fluorescently conjugated Ab and detected by flow cytometry (representative plots for each 
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treatment condition are shown). For all panels, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 using 
Student’s unpaired t-test (single transfer) or paired t-test (co-transfer), bars +/- error represent mean +/- 
SD, and all data is representative of 2 independent experiments. 
Figure 3. Reversed docking polarity of NP1-B17 and NP2-B17 TCRs. The top panels represent the 
overall TCR-pMHC complex of (a) NP1-B17 TCR-H-2Db-NP366, (b) NP2-B17 TCR-H-2D
b-NP366, (c) 
LC13-HLA-B8-FLR (Kjer-Nielsen et al., 2003) and (d) FS18-HLA-DR4-CL19 (Beringer et al., 2015). 
The TCRα chain is in light pink, the TCRβ chain is in pale blue, the H-2Db is represented in white 
cartoon, HLA-B8; pale cyan, HLA-DR4; yellow and pale orange for the β- and α-chain, respectively, 
and peptide; black stick. The bottom panels represent the TCR atomic footprints on the surface of each 
corresponding pMHC complex (MHC; white surface, and peptide; grey surface). The pie charts 
represent the relative contributions of each TCR segment to the interaction with each pMHC complex. 
The CDR1, 2 and 3 loops are coloured in teal, green and purple for the α-chain, in red, orange and 
yellow for the β-chain. Contact with the framework (FW) is coloured in magenta for the FWα and dark 
blue for the FWβ, and the spheres represent the centre of mass of Vα and Vβ, in pink and blue, 
respectively. The docking angle of each TCR-pMHC complex is depicted next to the footprint. The 
dashed circle highlights the unique section of MHC-I contacted by the NP1-B17 and NP2-B17 TCRs 
(residue 14-21 and 85-92). 
Figure 4. NP1-B17 TCR contacts with H-2D
b
-NP366. (a) Top view of the CDR3α loop (purple) 
interaction with H-2Db (white). The two loops outside the antigen-binding cleft of H-2Db are colored in 
black (residue 14-21 and 85-92). (b) Side view of the CDR3β loop (yellow) interaction with the H-2Db. 
(c, d). Interactions of the CDR2β (orange) and FWβ (pale blue) with H-2Db. The sphere represents 
Gly69. (e) NP1-B17 TCR interaction with the peptide (black stick) via the CDR2β (orange) and the 
FWβ segment. Blue and red dashed lines represent hydrophobic and polar interactions, respectively.  
Figure 5. TRBV17
+
 TCRs show a correlation between affinity and signal strength, and undergo 
thymic selection on H-2D
b 
molecule. (a) Surface representation of the H-2Db (white) and sphere 
representation of NP366 (pale cyan) complex. The colour depicts the impact of the pMHC-I residue on 
the NP1-B17 TCR binding, with black for no effect (<3-times the WT value), orange for a moderate 
effect (3 - 5-fold the WT value) and red for a critical effect (>5-times the WT value). (b) Surface 
representation of the NP1-B17 TCR (coloured in pale pink and blue for the α- and β-chains, 
respectively). The view is of the TCR-pMHC complex open in half (like a cut apple) showing the key 
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residues involved in the interaction. TCR residues have been color-coded according to the data in (c); 
green - mutants that improve signaling, dark grey - mutants that show >60% of pERK1/2 staining 
obtained with WT TCR (no impact), orange, mutants that show 10-60% of WT pERK1/2 staining 
(moderate impact), red - mutants that ablate signaling (<10%) (critical). (c) pERK1/2 staining in Jurkat 
TCR transductants expressing NP1-B17 TCR mutants containing single alanine substitutions, 
expressed relative to that induced by WT TCR. The bars are colored accordingly to the TCR segment 
to which each mutated residue belong, namely teal (CDR2α), purple (CDR3α), orange (CDR2β), blue 
(FWβ), yellow (CDR3β) or black for the WT TCR. The orange and red dashed lines represent 60 and 
10%, respectively, of the pERK1/2 staining compare to WT TCR staining. Data are representative of 2 
independent experiments. (d) Frequency of CD8+ T cells from pooled spleen and lymph nodes of B6 
WT, H-2Kb-/- and H-2Kb/Db-/- mice. Using tetramer-based naïve enrichment with the H-2Db-NP366 
tetramer, (e) the number of naïve H-2Db-NP366-specific CD8
+ T cells recovered from individual B6 WT 
and H-2Kb-/- mice and (f) the percentage of naïve H-2Db-NP366-specific CD8
+ T cells expressing 
TRBV17 was determined. * p<0.02, ****p<0.001, using a Mann-Whitney test. n=10-12 from 3 pooled 
experiments.  
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Table 1. NP1-B17 TCR affinity for H-2D
b
-NP366 and mutants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NB: no binding observed at the highest concentration tested (200 µM). ΔΔGeq = RTln(Kdmut/KdWT), 
where R is the gas constant and T is the temperature in Kelvin. Effect on affinity is negligible (*, less 
than 3-times the WT value), moderate (**, between 3 and 5-times the WT value) or critical (***, more 
than 5-times the WT value). 
  
H-2D
b
-NP366 Kdeq (µM) ΔΔGeq 
(kcal/mol) 
Effect on affinity 
 
WT 39.8 ± 4.5   
Mutant H-2D
b
 with NP366 Kdeq (µM) ΔΔGeq 
(kcal/mol) 
Effect on affinity 
 
E18A 133 ± 10 0.71 ** 
E19A 29.7 ± 0.9 -0.17 * 
Q65A 66.7 ± 0.8 0.30 * 
K68A 92.4 ± 1.0 0.49 * 
Q72A 52.5 ± 4.2 0.16 * 
R75A NB >> 0.95 *** 
V76A > 200 > 0.95 *** 
R79A > 200 > 0.95 *** 
N80A NB >> 0.95 *** 
A89V  135.5 ± 7.5 0.72 ** 
K146A > 200 > 0.95 *** 
Q149A 175 ± 5 0.87 ** 
E163A 59.8 ± 6.2 0.24 * 
H155A 76.4 ± 2.2 0.38 * 
Q65A-G69A-H155A 82.5 ± 1.1 0.43 * 
H-2D
b
 with mutant NP366 Kdeq (µM) ΔΔGeq 
(kcal/mol) 
Effect on affinity 
 
NP-A1N 147.5 ± 3.5 0.77 ** 
NP-N3A 66.2 ± 1.2 0.30 * 
NP-E4A 37.6 ± 0.9 -0.03 * 
NP-M6W 45.4 ± 1.5 0.07 * 
NP-M6A 97.5 ± 2.2 0.53 * 
NP-E7A > 200 > 0.95 *** 
NP-T8A > 200 > 0.95 *** 
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Table 2. NP1-B17 and NP2-B17 TCRs contacts with H-2D
b
-NP366 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations are as follows: FW, Framework residue; HB, hydrogen bond cut off distance 3.5 Å; SB, salt bridge cut off distance 5 Å; N, 
non-germline encoded; D, diversity; J, joining; VDW, van der Waals cutoff distance at 4 Å. 
TCR gene NP1-B17 NP2-B17  H-2D
b
  Bond type 
CDR3α-N Glu108-Oε1 Glu108-Oε1-Oε2 Arg79-NΗ1 VDW, SB 
CDR3α-N Thr109  Gly16, Leu17, Glu18 VDW 
CDR3α-N  Gly109 Glu18 VDW 
CDR3α-J Ser110  Leu82, Ala89 VDW 
CDR3α-J  Ser110 Arg75, Arg79 VDW 
CDR3α-J Gly111 Gly111 Arg79 VDW 
CDR3α-J Ser112-Oγ  Glu18-Oε2, Arg75-NΗ2 VDW, HB 
CDR3α-J  Ser112-Oγ Glu18-Oε2 VDW, HB 
CDR3α-J Trp113 Trp113 Arg75, Val76, Arg79,  VDW 
CDR3α-J Gln114-Oε1 Gln114-Oε1 Arg79-NH2 VDW, HB 
CDR2β  Tyr57 Tyr57 Gln72 VDW 
CDR2β  Ile64 Ile64 Gly69, Trp73 VDW 
FWβ  Asn66-Oδ1 Asn66-Oδ1 Val76, Asn80-Nδ2 VDW, HB 
FWβ  Arg67-O-NΗ2 Arg67-O-NΗ2-NH1 Lys146-Nζ‐O, Gln149-Oε1, Ser150 VDW, HB 
FWβ  Phe72  Ile142, Arg145, Lys146, Gln149 VDW 
FWβ   Phe72 Ile142, Arg145, Lys146 VDW 
FWβ  Glu74 Glu74-N Gln149-Oε1 VDW, HB 
FWβ  Phe76  Gln149 VDW 
FWβ  Gln77 Gln77 Gln149 VDW 
CDR3β-D Leu110-O Leu110 Gln72, Arg75-NΗ2-NΗ1, Val76 VDW, HB 
CDR3β-N  Asp111-Oδ1-Oδ2 Glu18-Oε1, Arg75-NH1, Glu19 VDW, HB. SB 
TCR gene NP1-B17  NP2-B17  NP366  Bond type 
CDR2β  Ile64  Asn5, Met6, Thr8 VDW 
CDR2β   Ile64 Thr8 VDW 
CDR2β  Leu65-O Leu65-O Glu7, Thr8-Oγ1-N VDW, HB 
FWβ  Asn66-Oδ1 Asn66-Oδ1 Thr8-Oγ1 VDW, HB 
FWβ  Arg67-NΗ2-Nε Arg67-NΗ2-Nε Glu7-Oε1-Oε2 VDW, SB 
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Supplemental Table 1. H-2D
b
-NP366-specific TCRs used for in vitro and in vivo expression 
TCR TRAV CDR1α CDR2α CDR3α TRAJ TRBV CDR1β CDR2β CDR3β TRBJ 
NP1-B17 14-2 DSTFNY IRSVSDK CAASETSGSWQLIFG 22 17 MNHDT YYDKIL CASSRDLGRDTYQYFG 2-5 
NP2-B17 14-2 DSTFNY IRSVSDK CAASEGSGSWQLIFG 22 17 MNHDT YYDKIL CASSAGLDAEQYFG 2-1 
NP3-B17 12-2 STYSPF SFTDNKR CASNTGYQNFYFG 49 17 MNHDT YYDKIL CASSRGTGAGNTLYFG 1-3 
NP1-B13 16 TRDSSYF QDSYKKEN CAMRVSGGSNAKLTFG  42 13-1 NSHNY SYGAGN CASSGGANTGQLYFG 2-2 
NP2-B13 16 TRDSSYF QDSYKKEN CAMRANSGTYQRFG 13 13-1 NSHNY SYGAGN CASSGGANTGQLYFG 2-2 
NP3-B13 16 TRDSSYF QDSYKKEN CAMRGSYGGRAQLIFG 15 13-1 NSHNY SYGAGN CASSGGANTGQLYFG 2-2 
NP4-B13 16 TRDSSYF QDSYKKEN CAMREGLGQGGRALIFG 15 13-1 NSHNY SYGAGN CASSGGGNTGQLYFG 2-2 
NP5-B13 16 TRDSSYF QDSYKKEN CAMRSAYQGGRALIFG 15 13-1 NSHNY SYGAGN CASSGGANTGQLYFG 2-2 
Sequence in red denotes CDR3 region.  
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Supplemental Table 2. Data collection statistics 
 
Data Collection Statistics NP1-B17 TCR-H-2D
b
-NP366 NP2-B17 TCR-H-2D
b
-NP366 
Temperature 100K 100K 
Space group P 212121 P 21 
Cell Dimensions (a,b,c) (Å) 
(°) 
92.23, 100.18, 469.46 48.02, 126.94, 80.48 
β = 105.66° 
Resolution (Å) 47.71 – 2.65  
(2.79 – 2.65) 
49.10 – 2.86  
(3.01 – 2.86) 
Total number of observations 1850936 (272722) 90916 (13017) 
Number of unique observations 127609 (18435) 21354 (3088) 
Multiplicity 14.5 (14.8) 4.3 (4.2) 
Data completeness (%) 100.0 (100.0) 99.0 (97.2) 
I/σI 14.4 (2.0) 10.6 (2.3) 
Rpim
a (%) 5.0 (59.1) 8.1 (38.3) 
Refinement Statistics   
Non-hydrogen atoms   
Protein 26498 6617 
Water 576 270 
Rfactor
b (%) 22.57 22.60 
Rfree
b (%) 24.88 27.23 
Rms deviations from ideality   
Bond lengths (Å) 0.007 0.007 
Bond angles (°) 0.95 0.87 
Ramachandran plot (%)   
Favoured 91.4 93.7 
Allowed  6.2 5.4 
Disallowed  1.4 0.9 
aRpim = Σhkl [1/(N-1)]
1/2  
Σi | Ihkl, i - <Ihkl> | / Σhkl <Ihkl> 
bRfactor = Σhkl  | | Fo | - | Fc | | / Σhkl | Fo | for all data except ≈ 5% which were used for Rfree calculation.  
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Supplemental Table 3. Thermal stability of pMHC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
H-2D
b
-NP366 Tm (°C) 
WT 49.2 ± 0.7 
Mutant H-2D
b
 with NP366 Tm (°C) 
E18A 47.6 ± 0.8 
E19A 48.5 ± 0.5 
Q65A 49.9 ± 0.5 
K68A 50.3 ± 0.2 
Q72A 56.9 ± 0.3 
R75A 48.0 ± 0.5 
V76A 51.0 ± 0.5 
R79A 49.4 ± 0.2 
N80A 49.6 ± 0.1 
A89V  49.0 ± 0.5 
K146A 41.8 ± 1.2 
Q149A 45.4 ± 0.8 
E163A 55.6 ± 0.2 
H155A 48.1 ± 0.4 
Q65A-G69A-H155A 47.8 + 0.8 
H-2D
b
 with mutant NP366 Tm (°C) 
NP-A1N 43.7 ± 0.2 
NP-N3A 47.0 ± 0.5 
NP-E4A 51.8 + 0.1 
NP-M6W 50.0 ± 0.5 
NP-M6A 57.8 + 1.0 
NP-E7A 49.3 + 0.2 
NP-T8A 48.8 + 0.5 
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Supplemental Figure Legends 
Supplemental Figure 1. Tetramer binding and functionality of H-2D
b
-NP366-specific TRBV17
+
 
and TRBV13-1
+
 T cells after IAV infection. 
(a) Levels of CD3ε staining on H-2Db-NP366-specific TRBV13
+ or TRBV17+ CD8+ T cells from 
spleens of mice at d10 after i.n. IAV infection. (b) Profiles of IFN-γ, TNF, and IL-2 staining following 
short term in vitro stimulation of NP1-B13 and NP1-B17 Rg cells harvested at d10 after co-transfer 
into recipient WT mice followed by IAV infection. (c) Proportion and (d) MFI of granzyme B 
production in NP1-B13 and NP1-B17 Rg cells at d7 after i.n. IAV infection.  
Supplemental Figure 2. Reversed docking polarity of NP1-B17 compared with Treg and KIR 
binding.  
Structure of the NP1-B17 TCR-H-2Db-NP366 complex (pink) superimposed on the structure of CD4 
Treg-HLA-DR4-C19 (green) (a) and with KIR3DL1-HLA-B57-LSS (yellow) (b). The bottom panels 
are side view of the top panels. 
Supplemental Figure 3. NP1-B17 TCR affinity measurement for H-2D
b
-NP366 and mutants. 
Binding curves of the NP1-B17 TCR against a concentration range of H-2Db-NP366 complex and H-
2Db mutants (a) or NP366 mutants (b) indicated by Response versus Concentration plots for duplicate 
experiments with error bars in black. Each H-2Db-NP366 complex is represented in colour, and the H-
2Db mutants (a) are divided into 3 panels for clarity. 
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Supplemental Experimental Procedures 
Generation of bone marrow-derived dendritic cells (BMDCs) 
Bone marrow was obtained by flushing the tibia and femur of one 8 week old 
C57BL/6 mouse with D-PBS/2% FBS. Red blood cells were removed with Red Blood 
Lysing Solution™ (Sigma-Aldrich). Bone marrow cells (6x106) were cultured in a 6 
well dish in complete T-cell medium supplemented with 10% FBS and GM-CSF (10 
ng/ml) (Peprotech) for 5 d at which point BMDCs were harvested and processed for 
T-cell signaling. 
T-cell signaling 
BMDCs (1x105) or DC2.4 cells (6 x 105) (provided as a kind gift from Professor 
Kenneth Rock, University of Massachusetts Medical School) were incubated with or 
without 1 M NP peptide for 1h at 37°C. Cells were re-suspended with 3x104 FACS-
purified GFP+ murine retrogenic NP1-B17, NP1-B13 T-cells, or a panel of 2 x 105 
Jurkat transductants expressing NP1-B17 wt and mutant TCRs and briefly spun down 
to allow for cell-cell conjugation for the indicated time points. To assess T cell 
signaling after CD3-crosslinking 3x104 FACS purified GFP+ murine retrogenic NP1-
B17 or NP1-B13 T-cells were incubated with 2.5 g/ml hamster anti-mouse 
CD3(145-2C11) for 15 min on ice. Cells were washed and stimulated with 20 g/ml 
rabbit anti-hamster IgG (Sigma) for 10 minutes at 37°C. T cells were fixed in BD 
CytofixTM Fixation Buffer (BD Biosciences) for 20 min at 37°C and permeabilized in 
methanol/acetone (50:50) overnight at -20°C. T-cells and TCR transductants were 
washed and processed for intracellular staining using either phospho-p44/42 MAPK 
(Erk1/2) Thr202/Tyr204 rabbit mAb (Cell Signaling) for 1h at room temperature 
followed by the incubation with rabbit IgG (H+L), F(ab’)2
 
fragment DyLight 649 
(Jackson ImmunoResearch), or Pacific Blue-conjugated mouse anti-human ERK1/2 
(pT202/pY204) (clone 20A) mAb. T-cells and TCR transductants were washed and 
data was collected using a CyAn ADP (Beckman Coulter) or a LSRII flow cytometer 
(BD Biosciences) and analysed using FlowJo8.7.7 (Tree Star Inc.) software. For cell 
sorting, an Influx (BD Biosciences) sorter was used.  
Protein expression, purification, crystallisation and structure determination 
The NP1-B17 and NP2-B17 TCRs as well as the wt and mutants pMHC complex 
were expressed, refolded and purified as previously described (Day et al., 2011). 
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Crystals of the NP1-B17 and NP2-B17 TCRs-H-2Db-NP366 complexes (5mg/ml) were 
grown by the vapour-diffusion method at 20°C in 10mM Tris-HCl pH 8, 150mM 
NaCl using 17% PEG 3350, 0.2 M K-Na-tartrate and 0.1 M Bis-Tris-Propane pH 7.5, 
and soaked in a cryoprotectant solution containing PEG concentration increased to 
30%(w/v) and flash frozen in liquid nitrogen. The data was collected on the MX2 
beamline at the Australian Synchrotron, Clayton using the ADSC-Quantum 315r 
CCD detector, processed using the XDS software (Leslie, 1992) and scaled using 
SCALA software (Evans, 2006) from the CCP4 suite (Winn et al., 2011). The 
structures were determined by molecular replacement using the PHASER (Read, 
2001) program with the LC13 TCR as the search model for the TCR (Protein Data 
Bank accession number, 1KGC (Kjer-Nielsen et al., 2002)) and the H-2Db for the 
MHC model without the peptide (Protein Data Bank accession number, 4HUU 
(Valkenburg et al., 2013)). Manual model building was conducted using the Coot 
software (Emsley and Cowtan, 2004) followed by maximum-likelihood refinement 
with the Buster program {Bricogne G., 2011 #276}. The TCRs were numbered 
according to the IMGT unique numbering system (Lefranc, 2003) whereby the CDR1 
loops start at residue number 27, the CDR2 loops start at number 56, and the CDR3 
loops start at residue number 105. The final model has been validated using the 
Protein Data Bank validation web site and the final refinement statistics are 
summarised in Supplementary Table 2. 
All molecular graphics representations were created using PyMol (DeLano, 2002). 
Thermal stability assay 
To assess the effect of each mutation on the pMHC complex stability, a thermal shift 
assay was performed. The fluorescent dye Sypro orange was used to monitor the 
protein unfolding. The thermal stability assay was performed in the Real Time 
Detection system (Corbett RotorGene 3000), originally designed for PCR. Each 
pMHC complex was in 10 mM Tris-HCl pH8, 150 mM NaCl, at two concentrations 
(5 and 10 µM) in duplicate, was heated from 29 to 95°C with a heating rate of 
1°C/min. The fluorescence intensity was measured with excitation at 530 nm and 
emission at 555 nm. The Tm, or thermal melt point, represents the temperature for 
which 50% of the protein is unfolded. Results are reported in Supplementary Table 
3. 
Surface Plasmon Resonance Measurement and Analysis 
All surface plasmon resonance experiments were conducted at 25C on the BIAcore 
3000 instrument with 10mM Tris-HCl, pH 8, 150mM NaCl, 0.005% surfactant P20 
and % BSA buffer. The NP1-B17 and NP2-B17 TCRs, as well as a negative control 
(LC13 (Gras et al., 2009)), bound to a CM5 sensor chip via amine coupling, and the 
pMHC was flown over the TCRs with a maximum concentration of 200 µM. The 
experiment was conducted as previously described (Gras et al., 2009) in duplicate 
with n=2. BIAevaluation Version 3.1 was used for data analysis with the 1:1 
Langmuir binding model, the results are summarized in Table 1. 
 
